Immunohistochemical expression of nuclear factor kappa-B/p65 and cyclooxygenase-2 in non-small cell lung cancer patients: Prognostic value and impact on survival

被引：0
|
作者：
El-Magd, Gehan H. Abo
Abd El-Fattah, Omnia
Saied, Eman M.
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2014年 / 44卷
关键词：
Lung cancer / Oncology; Bronchoscopy;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
P512
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Prognostic Value of Survival of MicroRNAs Signatures in Non-small Cell Lung Cancer
    Chen, Bo
    Gao, Tianshun
    Yuan, Weiwei
    Zhao, Weihong
    Wang, Tza-Huei
    Wu, Jianqing
    JOURNAL OF CANCER, 2019, 10 (23): : 5793 - 5804
  • [42] Sestrin2 expression is a favorable prognostic factor in patients with non-small cell lung cancer
    Chen, Kuan-Bing
    Xuan, Ying
    Shi, Wen-Jun
    Chi, Feng
    Xing, Rui
    Zeng, Yue-Can
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2016, 8 (04): : 1903 - 1909
  • [43] Cyclooxygenase-2 Genetic Variants Are Associated with Survival in Unresectable Locally Advanced Non-Small Cell Lung Cancer
    Bi, Nan
    Yang, Ming
    Zhang, Li
    Chen, Xiabin
    Ji, Wei
    Ou, Guangfei
    Lin, Dongxin
    Wang, Luhua
    CLINICAL CANCER RESEARCH, 2010, 16 (08) : 2383 - 2390
  • [44] Prognostic value of histology in patients with non-small cell lung cancer
    Charloux, A
    Hedelin, G
    Dietemann, A
    Ifoundza, T
    Roeslin, N
    Pauli, G
    Quoix, E
    LUNG CANCER, 1997, 17 (01) : 123 - 134
  • [45] Hypermetabolism is an independent prognostic factor of survival in metastatic non-small cell lung cancer patients
    Jouinot, Anne
    Ulmann, Guillaume
    Vazeille, Clara
    Durand, Jean-Philippe
    Boudou-Rouquette, Pascaline
    Arrondeau, Jennifer
    Tlemsani, Camille
    Fournel, Ludovic
    Alifano, Marco
    Wislez, Marie
    Chapron, Jeanne
    Le Bris, Camille
    Mansuet-Lupo, Audrey
    Damotte, Diane
    Neveux, Nathalie
    De Bandt, Jean-Pascal
    Alexandre, Jerome
    Cynober, Luc
    Goldwasser, Francois
    CLINICAL NUTRITION, 2020, 39 (06) : 1893 - 1899
  • [46] ALI Could Be a One of Prognostic Survival Factor for Non-Small Cell Lung Cancer Patients
    Hamamoto, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S996 - S997
  • [47] Correlation between cyclooxygenase-2 and tumor angiogenesis in non-small cell lung cancer
    Kim, HS
    Youm, HR
    Lee, JS
    Min, KW
    Chung, JH
    Park, CS
    LUNG CANCER, 2003, 42 (02) : 163 - 170
  • [48] Significance of survivin expression: Prognostic value and survival in stage III non-small cell lung cancer
    Wang, Meng
    Liu, Bao-Gang
    Yang, Zhao-Yang
    Hong, Xuan
    Chen, Gong-Yan
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2012, 3 (06) : 983 - 988
  • [49] The Prognostic and Functional Impact of Sprouty 2 Expression in Non-small Cell Lung Cancer
    Acikgoz, Yusuf
    Yildirim, Fatma Unal
    Esen, Selin Akturk
    Ucar, Gokhan
    Ergun, Yakup
    Bal, Oznur
    Dogan, Mutlu
    Uncu, Dogan
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2023, 46 (12): : 543 - 550
  • [50] Prognostic Value of the Glasgow Prognostic Score on Overall Survival in patients with Advanced Non-Small Cell Lung Cancer
    Pan, Mingmei
    Zhao, Yun
    He, Jianbo
    Wu, Huanqiong
    Pan, Yujia
    Yu, Qitao
    Zhou, Shaozhang
    JOURNAL OF CANCER, 2021, 12 (08): : 2395 - 2402
12345